Menu
Menu
Dr. Mohammad Afroz Jalil is a visionary leader with 25 years of diverse experience in the pharmaceutical industry. Known for his strategic acumen and innovative mindset, Dr. Jalil has held pivotal leadership roles in global organizations such as Roche and Sanofi. He specializes in Organizational Transformation & Leadership, driving businesses toward sustainable growth and operational excellence.
Dr. Mohammad Afroz Jalil served as the Managing Director of Roche Bangladesh, where he transformed the organization into a high-performing operation.
❏ Increased annual turnover from BDT 600 million to BDT 1.4 billion, maintaining a 30% market share in a highly competitive environment.
❏ Streamlined management operations, boosting efficiency by 15% and cutting costs by 16%.
❏ Introduced Bangladesh's first health insurance scheme for cancer treatment.
❏ Enhanced diagnostic capabilities for breast cancer, setting global standards for Her2 testing.
❏ Advocated for rare diseases like Haemophilia, incorporating them into national healthcare priorities.
❏ Collaborated with regulators to improve healthcare access and introduce innovative treatments.
❏ Facilitated expedited approval and delivery of critical COVID-19 treatments during the pandemic.
Dr. Jalil spent 13 years at Sanofi, holding progressively senior leadership roles, including Director of the Specialty Unit. He played a pivotal role in driving organizational growth, expanding the Diabetes, Cardiology, and Oncology portfolios into market leaders.
❏ Transformed the Diabetes & Cardiology portfolio into a €12 million business, contributing 45% of the company's revenue.
❏ Expanded the product line with groundbreaking innovations like portable HbA1c testing, revolutionizing diabetes diagnosis in Bangladesh.
❏ Launched market-leading brands such as Lantus, Amaryl, and Texotere.
❏ Managed a team of 135 professionals, overseeing recruitment, training, and performance development.
❏ Introduced novel therapeutic solutions for diabetes, oncology, and rare diseases. And Designed medical strategies for groundbreaking products like Enoxaparin (Clexane).
Dr. Mohammad Afroz Jalil is currently serving as the Co-Founder & Chief Strategy Officer at NAMMCON. In this role, he leverages over 25 years of expertise in strategic leadership, organizational transformation, and innovative healthcare solutions.
Leading strategic initiatives that align businesses with global standards.
Delivering localized, innovative solutions for sustainable growth.
Driving organizational transformation through expert advisory services.
All Rights reserved NAMMCON
Designed & Developed by Crowds Reach Limited